Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
15 studies found for:    Open Studies | "Aspergillosis"
Show Display Options
Rank Status Study
1 Recruiting Exhaled Breath Analysis in the Early Detection of Aspergillosis
Condition: Invasive Aspergillosis
Intervention:
2 Recruiting Bronchoalveolar Lavage Lateral-Flow Device Test for Invasive Pulmonary Aspergillosis: a Multicenter Study
Condition: Invasive Pulmonary Aspergillosis
Intervention: Device: Lateral Flow Device Test
3 Recruiting A Randomized Trial of Itraconazole in Acute Stages of Allergic Bronchopulmonary Aspergillosis
Condition: Allergic Bronchopulmonary Aspergillosis
Interventions: Drug: Itraconazole;   Drug: Glucocorticoids
4 Not yet recruiting PET/CT Guided Antifungal Stewardship in Invasive Pulmonary Aspergillosis
Condition: Aspergillosis and Haematological Malignancy
Interventions: Device: imaging 18F-FDG-PET/CT;   Biological: Blood collection
5 Not yet recruiting An Evaluation of Sequential Computed Tomography of the Chest in Management of Invasive Pulmonal Aspergillosis in Neutropenic Patients With Haematological Malignancies
Condition: Invasive Aspergillosis
Intervention:
6 Not yet recruiting A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of PC945
Condition: Aspergillosis
Interventions: Drug: PC945 - single doses;   Drug: Placebo - single doses;   Drug: PC945 - repeat doses;   Drug: Placebo - repeat doses
7 Not yet recruiting Radiolabelled IV and Oral Metabolism Study of F901318
Condition: Invasive Aspergillosis
Interventions: Drug: IV F901318;   Drug: Oral F901318
8 Not yet recruiting Multiple Ascending Oral Dose Study of F901318 in Healthy Subjects
Condition: Invasive Aspergillosis
Interventions: Drug: F901318 Dose level A oral;   Drug: Placebo dose level A oral;   Drug: F901318 Dose level B oral;   Drug: Placebo dose level B oral;   Drug: F901318 Dose level C oral;   Drug: Placebo Dose level C oral
9 Recruiting Study of Potential for Interaction of Fluconazole With F901318
Condition: Invasive Aspergillosis
Interventions: Drug: F901318;   Drug: Fluconazole
10 Recruiting Concentrations of Voriconazole in Blood and BAL-fluid After Inhalation and Oral Administration
Condition: Invasive Aspergillosis
Intervention: Drug: Voriconazole
11 Recruiting Assessing the Safety and Efficacy of MK-5592 (Posaconazole) in Japanese Participants With Fungal Infection (MK-5592-101)
Condition: Aspergillosis
Interventions: Drug: Posaconazole;   Drug: Voriconazole
12 Recruiting A Study of the Safety and Efficacy of Posaconazole Versus Voriconazole for the Treatment of Invasive Aspergillosis (MK-5592-069)
Condition: Fungal Infections
Interventions: Drug: Posaconazole;   Drug: Voriconazole
13 Recruiting Lung MRI and Allergic Broncho-pulmonary Aspergillosis in Cystic Fibrosis
Conditions: Pulmonary Cystic Fibrosis;   ABPA
Intervention:
14 Not yet recruiting Study on Safety and Pharmacokinetics of Intravenous F901318 for Fungal Prophylaxis in AML Patients
Conditions: Pulmonary Aspergillosis - Invasive;   Acute Myeloid Leukemia
Interventions: Drug: F901318;   Drug: Caspofungin
15 Not yet recruiting King's Invasive Aspergillosis Study II
Conditions: Aplastic Anemia;   Leukemia, Myeloid, Acute;   Myelodysplastic Syndromes;   Bone Marrow Transplantation
Intervention: Drug: Posaconazole

Study has passed its completion date and status has not been verified in more than two years.